Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600123852Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative pain comparing Oliceridine group with Hydromorphone group (2 arms). Primary endpoints: Visual Analog Scale score, Postoperative opioid-related adverse events and 1 more. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600123852.